Financials Amarin Corporation plc

Stocks

AMRN

US0231114044

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 15:14:07 2026-08-11 EDT			5-day change	1st Jan Change
14.10 ^USD	-0.11%		-2.29%	+0.82%

07-29	Amarin Corporation plc, Q2 2026 Earnings Call, Jul 29, 2026
07-29	Tranche Update on Amarin Corporation plc's Equity Buyback Plan announced on May 1, 2024.	CI

Projected Income Statement: Amarin Corporation plc

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	583.2	369.2	306.9	228.6	213.6	171.5	164.6	157.9
Change	-	-36.69%	-16.87%	-25.51%	-6.55%	-19.71%	-4.03%	-4.09%
EBITDA ¹	24.81	-47.5	-67.43	-91.7	-50.17	-43.57	-35.05	-35.02
Change	-	-291.49%	-41.95%	-36%	45.29%	13.15%	19.55%	0.09%
EBIT ¹	24.22	-74.26	-67.59	-91.8	-50.17	-43.57	-35.05	-35.02
Change	-	-406.64%	8.99%	-35.82%	45.35%	13.16%	19.55%	0.09%
Interest Paid	-0.129	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	11.29	-103.8	-53.67	-77.2	-36.05	-31.25	-23.48	-23.09
Change	-	-1,019.36%	48.3%	-43.84%	53.31%	13.31%	24.86%	1.66%
Net income ¹	7.729	-105.8	-59.11	-82.18	-38.8	-29.68	-23.48	-23.09
Change	-	-1,468.91%	44.13%	-39.03%	52.79%	23.5%	20.89%	1.66%
Announcement Date	3/1/22	3/1/23	2/29/24	3/12/25	2/25/26	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2
Net sales ¹	142	144.5	94.63	94.44	89.88	90.24	85.98	80.17	66.06	74.71	56.52	67.49	42.3	62.31	42.02	72.74	49.67	49.22	45.13	42.21	41.42	43.56	41.94	39.92
Change	-	1.73%	-34.51%	-0.2%	-4.83%	0.41%	-4.73%	-6.76%	-17.6%	13.11%	-24.35%	19.41%	-37.33%	47.3%	-32.56%	73.12%	-31.72%	-0.91%	-8.3%	-6.47%	-1.87%	5.16%	-3.72%	-4.82%
EBITDA ¹	1.186	15.88	-27.53	-37.48	-5.006	-3.029	-17.28	-	-	-4.804	-	-0.492	-25.14	-	-	-15.98	-11.1	-6.324	-11.33	-12.01	-10.85	-8.589	-6.806	-9.894
Change	-	1,238.87%	-273.35%	-36.14%	86.64%	39.49%	-470.42%	-	-	-	-	-	-5,010.37%	-	-	-	30.54%	43.04%	-79.21%	-5.96%	9.62%	20.87%	20.76%	-45.37%
EBIT ¹	1.042	15.74	-28.31	-37.62	1.427	-9.766	-17.34	-23.96	-21.45	-4.837	-13.58	-0.524	-25.17	-52.52	-16.76	-15.98	-11.1	-6.325	-11.33	-12.01	-10.85	-8.589	-6.806	-9.894
Change	-	1,410.08%	-279.9%	-32.9%	103.79%	-784.37%	-77.57%	-38.16%	10.47%	77.45%	-180.81%	96.14%	-4,703.05%	-108.69%	68.1%	4.6%	30.54%	43.03%	-79.19%	-5.96%	9.63%	20.87%	20.76%	-45.37%
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT)	-12.97	16.39	-28.35	-64.8	-3.883	-6.773	-14.5	-17.92	-18.81	-2.449	-8.655	2.892	-21.53	-49.91	-	-13.45	-8.115	-	-	-	-	-	-	-
Change	-	226.42%	-272.94%	-128.57%	94.01%	-74.43%	-114.03%	-23.59%	-5%	86.98%	-253.41%	133.41%	-844.43%	-131.81%	-	-	39.67%	-	-	-	-	-	-	-
Net income	-13.15	14.7	-31.56	-69.96	-5.14	0.856	-16.46	-17.56	-19.31	-5.781	-9.953	1.522	-25.13	-48.62	-15.7	-14.14	-7.738	-1.224	-10.51	-	-	-	-	-
Change	-	211.76%	-314.74%	-121.64%	92.65%	116.65%	-2,022.9%	-6.68%	-9.97%	70.06%	-72.17%	115.29%	-1,751.38%	-93.44%	67.71%	9.93%	45.27%	84.18%	-758.82%	-	-	-	-	-
Announcement Date	11/3/21	3/1/22	5/4/22	8/3/22	10/27/22	3/1/23	5/3/23	8/2/23	11/1/23	2/29/24	5/1/24	7/31/24	10/30/24	3/12/25	5/7/25	7/30/25	10/29/25	2/25/26	4/29/26	7/29/26	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Amarin Corporation plc

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt ¹	-219	-218	-199	-121	-135	-156	-156	-154
Change	-	0.46%	8.72%	39.2%	-11.57%	-15.85%	0%	1.28%
Announcement Date	3/1/22	3/1/23	2/29/24	3/12/25	2/25/26	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Amarin Corporation plc

Fiscal Period: December	2020	2021	2022	2023	2024	2025
CAPEX ¹	0.252	-	-	0.024	-	-
Change	-	-	-	-	-	-
Free Cash Flow (FCF) ¹	-19.71	70.02	-85.62	-19.45	8.001	-25.5
Change	-	455.21%	-222.29%	77.28%	141.13%	-418.78%
Announcement Date	2/25/21	3/1/22	3/1/23	2/29/24	3/12/25	3/2/26

¹USD in Million

Estimates

Forecast Financial Ratios: Amarin Corporation plc

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-	4.25%	-12.87%	-21.97%	-40.11%	-23.48%	-25.4%	-21.29%	-22.18%
EBIT Margin (%)	-	4.15%	-20.12%	-22.02%	-40.15%	-23.48%	-25.4%	-21.29%	-22.18%
EBT Margin (%)	-	1.94%	-28.12%	-17.49%	-33.77%	-16.87%	-18.22%	-14.26%	-14.62%
Net margin (%)	-	1.33%	-28.66%	-19.26%	-35.95%	-18.16%	-17.3%	-14.26%	-14.62%
FCF margin (%)	-	-11.41%	-48.94%	2.24%	-13.57%	-	-	-	-
FCF / Net Income (%)	-	-860.82%	170.78%	-11.64%	37.75%	-	-	-	-
Profitability
ROA	-1.33%	1.49%	-4.75%	-1.27%	-4.56%	-1.28%	-	-	-
ROE	-2.91%	1.19%	-16.76%	-10.3%	-15.83%	-8.21%	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	0.16%	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-1.26%	-	-	-	-	-	-
CAPEX / FCF (%)	-	-	-0.33%	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	33.64	29.64	27.09	23.68	-	-	-	-
Change	-	-	-11.9%	-8.62%	-12.57%	-	-	-	-
EPS ¹	-	0.4	-5.2	-3	-4	-0.09	-0.07	-0.06	-0.06
Change	-	-	-1,400%	42.31%	-33.33%	97.75%	22.22%	14.29%	0%
Nbr of stocks (in thousands)	-	19,781	20,191	20,415	20,567	20,793	21,123	21,123	21,123
Announcement Date	-	3/1/22	3/1/23	2/29/24	3/12/25	2/25/26	-	-	-